BCG TICE strain

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

Tuberculosis

Phase 1

Challenge Model for Assessment of Human TB Immunity

CompletedNCT01868464

National Institute of Allergy and Infectious Diseases (NIAID)Tuberculosis

Start: 2014-05-28End: 2017-12-18Updated: 2020-01-27

Safety and Challenge Study of BCG TICE(R) Vaccination to Test Tuberculosis Immunity in Heathy Humans

WithdrawnNCT06845358

National Institute of Allergy and Infectious Diseases (NIAID)Tuberculosis

Start: 2025-11-26End: 2026-09-01Updated: 2025-12-17

Related Papers

Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo

The Journal of Infectious Diseases2023-11-298 citations